Clindacam-600 Injection

Clindamycin 600 mg / 4 ml Injection — IV Lincosamide for Severe Infections

Clindacam-600 Injection — Clindamycin 600 mg / 4 ml from Trumac Healthcare PCD Pharma Franchise India

Composition Clindamycin 600 mg / 4 ml
Dosage Form Injection (IV/IM)
Pack Type Ampoule
Pack Size 4 ml Ampoule
MRP ₹ 254
Therapy Dermatology + Antibiotic + Injectable — Lincosamide Antibiotic (Parenteral)
Storage Store below 25 °C in a dry place, protected from light. Do not freeze.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Clindacam-600 Injection

Clindacam-600 Injection contains Clindamycin 600 mg per 4 ml for parenteral administration in severe infections. Used in hospitalised patients with severe MRSA infections, necrotising fasciitis (where clindamycin’s toxin-suppression action is critical), severe anaerobic infections and septic arthritis/osteomyelitis.

Clindamycin is one of the recommended antibiotics for necrotising fasciitis combined with a beta-lactam because of its ability to suppress bacterial exotoxin production beyond simple bactericidal action.

Clindacam-600 Injection is manufactured by Trumac Healthcare under WHO-GMP injectable conditions. Available for monopoly-based PCD pharma franchise, government tenders and third-party manufacturing — a hospital SKU.

Indications

  • Severe MRSA skin and soft-tissue infections
  • Necrotising fasciitis (with beta-lactam)
  • Toxic shock syndrome
  • Severe intra-abdominal and pelvic anaerobic infections
  • Septic arthritis and osteomyelitis
  • Aspiration pneumonia with anaerobic component

Mechanism of Action

Same as oral clindamycin — 50S ribosomal subunit binding, protein synthesis inhibition, plus exotoxin suppression.

Dosage & Administration

Adults: 600–900 mg every 8 hours by slow IV infusion or IM. Strictly hospital use. Step down to oral when clinical improvement allows.

Side Effects

Infusion-site pain, phlebitis. Diarrhoea (including C. difficile colitis), nausea, rash. Rare: pseudomembranous colitis, hepatotoxicity, hypersensitivity.

Contraindications & Precautions

Hypersensitivity to lincosamides. History of C. difficile colitis. Severe hepatic impairment.

Storage

Store below 25 °C in a dry place, protected from light. Do not freeze.

PCD Pharma Franchise & Third-Party Manufacturing
Clindacam-600 Injection is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Clindacam-600 Injection used for?

Clindacam-600 Injection contains Clindamycin 600 mg/4 ml. Used as per the indications described above.

How should Clindacam-600 Injection be taken?

As directed by your physician. Complete the prescribed course.

Is Clindacam-600 Injection available for PCD pharma franchise?

Yes, Trumac Healthcare offers Clindacam-600 Injection on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Clindacam-600 Injection be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Clindacam-600 Injection WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.